Humoral response after SARS-CoV-2 vaccination in patients undergoing maintenance haemodialysis: loss of immunity, third dose and non-responders

Nephrol Dial Transplant. 2022 Jan 25;37(2):390-392. doi: 10.1093/ndt/gfab299.

Authors

Thomas Robert^{1

2}, Guillaume Lano^{1

3}, Matthieu Giot¹, Toscane Fourié⁴, Xavier de Lamballeri⁴, Océane Jehel¹, Dammar Bouchouareb¹, Philippe Brunet^{1

3}, Laetitia Ninove⁴, Stéphane Burtey^{1

3}

Affiliations

¹ Centre of Nephrology and Renal Transplantation, Hôpital de la Conception, CHU de Marseille, Marseille, France.
² MMG, Bioinformatics & Genetics, UMR_S910, Aix-Marseille Université, Marseille, France.
³ Aix-Marseille Univ, INSERM, INRAE, C2VN, Marseille, France.
⁴ Unité des Virus Émergents (UVE: Aix-Marseille Univ, IRD 190, Inserm 1207, IHU Méditerranée Infection), Marseille, France.

PMID: 34643714
DOI: 10.1093/ndt/gfab299

No abstract available

MeSH terms

Antibodies, Viral
COVID-19 Vaccines
COVID-19*
Humans
Renal Dialysis
SARS-CoV-2*
Vaccination

Substances

Antibodies, Viral
COVID-19 Vaccines